Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Neven

Showing results (381-390 of 384) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 384 results.
American Journal of Human Genetics|December 18, 2018
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer SubtypesNasim Mavaddat, Kyriaki Michailidou, Joe Dennis, et al.
Nature Genetics|January 9, 2020
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genesLaura Fachal, Hugues Aschard, Jonathan Beesley, et al.
Nature|October 24, 2017
Association analysis identifies 65 new breast cancer risk lociKyriaki Michailidou, Sara Lindström, Joe Dennis, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Pageof 39

Showing results (381-390 of 384) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 384 results.
American Journal of Human Genetics|December 18, 2018
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer SubtypesNasim Mavaddat, Kyriaki Michailidou, Joe Dennis, et al.
Nature Genetics|January 9, 2020
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genesLaura Fachal, Hugues Aschard, Jonathan Beesley, et al.
Nature|October 24, 2017
Association analysis identifies 65 new breast cancer risk lociKyriaki Michailidou, Sara Lindström, Joe Dennis, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Pageof 39